- Home
- Publications
- Publication Search
- Publication Details
Title
Ustekinumab for the treatment of Crohn’s disease
Authors
Keywords
-
Journal
Immunotherapy
Volume 5, Issue 8, Pages 803-815
Publisher
Future Medicine Ltd
Online
2013-08-01
DOI
10.2217/imt.13.81
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Toll-like receptor signaling and regulation of intestinal immunity
- (2013) Karishma Kamdar et al. Virulence
- Ustekinumab for Peristomal Pyoderma Gangrenosum
- (2012) Marianne Fahmy et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Peripheral Lymph Node Recurrence of Tuberculosis After Ustekinumab Treatment
- (2012) Ana I. Sánchez-Moya et al. ARCHIVES OF DERMATOLOGY
- Anti-TNF Monoclonal Antibodies in Inflammatory Bowel Disease: Pharmacokinetics-Based Dosing Paradigms
- (2012) I Ordás et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Determinants of colonic barrier function in inflammatory bowel disease and potential therapeutics
- (2012) Nina A. Hering et al. JOURNAL OF PHYSIOLOGY-LONDON
- Severely recalcitrant pyoderma gangrenosum successfully treated with ustekinumab
- (2012) Ari M. Goldminz et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Discovery and mechanism of ustekinumab
- (2012) Jacqueline M. Benson et al. mAbs
- Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
- (2012) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Review article: causative factors and the clinical management of patients with Crohn’s disease who lose response to anti-TNF-α therapy
- (2011) S. Danese et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- New Interleukin-23 Pathway Inhibitors in Dermatology
- (2011) Marta Kurzeja et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Glucocorticosteroid Therapy in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
- (2011) Alexander C Ford et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Efficacy of Immunosuppressive Therapy for Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
- (2011) Khurram J Khan et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Interleukin-23: A key cytokine in inflammatory diseases
- (2011) Emilie Duvallet et al. ANNALS OF MEDICINE
- Interleukin 23 Expression in Pyoderma Gangrenosum and Targeted Therapy With Ustekinumab
- (2011) Emmanuella Guenova ARCHIVES OF DERMATOLOGY
- Malignant melanoma during ustekinumab therapy of Crohnʼs disease
- (2011) Laura M. Ehmann et al. INFLAMMATORY BOWEL DISEASES
- Therapeutic targeting of the IL-12/23 pathways: generation and characterization of ustekinumab
- (2011) Jacqueline M Benson et al. NATURE BIOTECHNOLOGY
- Ulcerative Colitis
- (2011) Silvio Danese et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting leukocyte migration and adhesion in Crohn’s disease and ulcerative colitis
- (2011) Saskia Thomas et al. INFLAMMOPHARMACOLOGY
- Pyoderma gangraenosum
- (2010) Uwe Wollina et al. CURRENT OPINION IN RHEUMATOLOGY
- The use of ustekinumab in autoimmune disease
- (2010) Caitriona Ryan et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Ustekinumab
- (2010) Oya Cingoz mAbs
- Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
- (2010) Jean Frédéric Colombel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Relationship of C-Reactive Protein With Clinical Response After Therapy With Ustekinumab in Crohn's Disease
- (2009) Gary P Toedter et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Ustekinumab: Lessons Learned from Targeting Interleukin-12/23p40 in Immune-Mediated Diseases
- (2009) Michael Elliott et al. Annals of the New York Academy of Sciences
- Population Pharmacokinetic Modeling of Ustekinumab, a Human Monoclonal Antibody Targeting IL-12/23p40, in Patients With Moderate to Severe Plaque Psoriasis
- (2009) Yaowei Zhu et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Inflammatory Bowel Disease
- (2009) Clara Abraham et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical pharmacology and pharmacogenetics of thiopurines
- (2008) Srikumar Sahasranaman et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- A Randomized Trial of Ustekinumab, a Human Interleukin-12/23 Monoclonal Antibody, in Patients With Moderate-to-Severe Crohn's Disease
- (2008) William J. Sandborn et al. GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started